Previous Close | 142.68 |
Open | 143.21 |
Bid | 141.59 x 1100 |
Ask | 143.54 x 1000 |
Day's Range | 141.97 - 143.38 |
52 Week Range | 87.59 - 144.03 |
Volume | |
Avg. Volume | 1,098,779 |
Market Cap | 34.748B |
Beta (5Y Monthly) | 1.08 |
PE Ratio (TTM) | 49.76 |
EPS (TTM) | 2.88 |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | 1.44 (1.01%) |
Ex-Dividend Date | Feb 20, 2024 |
1y Target Est | 145.71 |
Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Xylem Inc. (XYL) continued its streak of surpassing revenue expectations.
Xylem (XYL) benefits from strength in the M&CS segment and the acquisition of Evoqua. Its measures to reward its shareholders are encouraging.